New aspects of amanita poisoning.
D000546:Amanitins / Q000097:blood* / Q000378:metabolism / Q000652:urine; D001646:Bile / Q000032:analysis; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D002606:Charcoal / Q000627:therapeutic use; D004764:Enterohepatic Circulation; D005374:Filtration; D005751:Gastric Lavage; D006464:Hemoperfusion; D006801:Humans; D007419:Intestinal Secretions / Q000032:analysis; D008099:Liver / Q000378:metabolism*; D008115:Liver Regeneration; D009145:Mushroom Poisoning / Q000628:therapy; D012319:RNA Polymerase II / Q000037:antagonists & inhibitors; D012320:RNA Polymerase III / Q000037:antagonists & inhibitors; D012333:RNA, Messenger / Q000037:antagonists & inhibitors; D006435:Renal Dialysis; D012838:Silymarin / Q000627:therapeutic use; D008063:Thioctic Acid / Q000627:therapeutic use; D013995:Time; D014158:Transcription, Genetic / Q000187:drug effects
D000546:Amanitins; D012333:RNA, Messenger; D012838:Silymarin; D002606:Charcoal; D008063:Thioctic Acid; D012319:RNA Polymerase II; D012320:RNA Polymerase III